| Detective Flow Imaging Endoscopic Ultrasonography in Subepithelial Lesions (NCT05474794) | Instituto Ecuatoriano de Enfermedades Digestivas | 2022-07-20 |
| Liver Transplantation for Unresectable GIST Liver Metastases (NCT04825470) | Hospital Universitario Virgen de la Arrixaca | 2022-05-01 |
| Exploring the Molecular Mechanism Based on KIT Mutation (NCT05895942) | Xijing Hospital | 2021-09-10 |
| French Long Term Registry With Longitudinal Follow up of PDGFRA D842V-GIST Patients (NCT04927260) | Centre Leon Berard | 2021-03-31 |
| Preoperative Radiotherapy in Patients at High Risk of Postoperative Pancreatic Fistula After Pancreatoduodenectomy (NCT05641233) | Erasmus Medical Center | 2020-12-01 |
| Study in Low Risk Gastrointestinal Stromal Tumor (GISTs) (NCT04599660) | Italian Sarcoma Group | 2020-11-25 |
| Clinical Evaluation of Genetron D842V PCR Kit in GIST Patients (NCT05400018) | Genetron Health | 2020-11-20 |
| NIR Fluorescence Imaging With ICG for the Intraoperative Identification of Gastrointestinal Stromal Cell Tumours (NCT04761172) | Leiden University Medical Center | 2020-06-17 |
| Long-term Surival of GIST Patients ≥ 10 Years on Imatinib (NCT04097093) | European Organisation for Research and Treatment of Cancer - EORTC | 2020-06-01 |
| Selinexor as Single Agent and With Imatinib in Metastatic and/or Unresectable Gastrointestinal Stromal Tumors (SeliGIST) (NCT04138381) | Grupo Espanol de Investigacion en Sarcomas | 2019-08-16 |
| The PIONEER Initiative: Precision Insights On N-of-1 Ex Vivo Effectiveness Research Based on Individual Tumor Ownership (Precision Oncology) (NCT03896958) | SpeciCare | 2019-03-21 |
| Temozolomide (TMZ) In Advanced Succinate Dehydrogenase (SDH)-Mutant/Deficient Gastrointestinal Stromal Tumor (GIST) (NCT03556384) | Adam Burgoyne, MD, PhD | 2018-09-12 |
| A Phase I/II Study of Regorafenib Plus Avelumab in Solid Tumors (NCT03475953) | Institut Bergonié | 2018-05-04 |
| (VOYAGER) Study of Avapritinib vs Regorafenib in Patients With Locally Advanced Unresectable or Metastatic GIST (NCT03465722) | Blueprint Medicines Corporation | 2018-03-26 |
| To Compare the Efficacy of Surgery Followed by Sunitinib With Surgery Followed by Imatinib in GIST Patients With Progression on Imatinib. (NCT03424876) | Peking University | 2017-06-02 |
| Long Outcome of Endoscopic Submucosal Dissection for Small Gastrointestinal Stromal Tumors (<2cm) (NCT03082079) | Nanfang Hospital, Southern Medical University | 2017-06-01 |
| Familial Investigations of Childhood Cancer Predisposition (NCT03050268) | St. Jude Children's Research Hospital | 2017-04-06 |
| Distress, Medication Adherence and Care Needs in Patients With CML and GIST Receiving Oral Targeted Therapy (NCT03880617) | National Taiwan University Hospital | 2015-03-25 |
| Phase II Trial of Vandetanib in Children and Adults With Wild-Type Gastrointestinal Stromal Tumors (NCT02015065) | National Cancer Institute (NCI) | 2013-12-14 |
| Clinical Registry of nCLE in Masses and Cystic Tumors of the Pancreas, Lymph Nodes, Submucosal Lesions of the GI Tract (NCT01770405) | Mauna Kea Technologies | 2013-09-01 |
| A Phase 2 Trial of Ponatinib in Participants With Metastatic and/or Unresectable Gastrointestinal Stromal Tumor (NCT01874665) | Ariad Pharmaceuticals | 2013-06-05 |
| LRG GIST Patient Registry (NCT07697248) | The Life Raft Group | 2013-04-01 |
| Evaluation of a New EUS-guided Needle (ProCore) Comparing to EUS-TCB Needle (Quick-Core) (NCT01768325) | Indiana University | 2012-01-01 |
| Non-Interventional Retrospective Correlation Of Tumor Mutational Status To Clinical Benefit Of GIST Patients Treated With Sunitinib (NCT01459757) | Pfizer | 2011-10-01 |
| Vaccine Therapy in Treating Patients With Metastatic Solid Tumors (NCT01376505) | Robert Wesolowski | 2011-06-21 |
| Efficacy of Pazopanib in Gastrointestinal Stromal Tumors (GIST) (NCT01323400) | Centre Leon Berard | 2011-03-01 |
| Evaluation of Cognitive Function of Patients With Sunitinib or Sorafenib (NCT01246843) | Radboud University Medical Center | 2009-07-01 |
| Trial of Tasigna (Nilotinib) 400 mg Twice Daily Alone or With Gleevec (Imatinib Mesylate) 400 mg Daily for Patients With Advanced Gastrointestinal Stromal Tumor (GIST) (NCT01089595) | Fox Chase Cancer Center | 2009-02-01 |
| Study of the Immunoresponse in Patients Treated With a Tyrosine Kinase Inhibitor (NCT00979381) | Radboud University Medical Center | 2008-10-01 |
| 11C-Acetate PET/CT Non-FDG-Avid Tumors (NCT00687778) | Tel-Aviv Sourasky Medical Center | 2008-05-01 |
| Study on the Influence of Sunitinib and Sorafenib on Fatigue, QoL, Depression in Patients With Metastatic RCC or GIST (NCT00979329) | Radboud University Medical Center | 2008-05-01 |
| An Open-Label, 18FDG-PET Pharmacodynamic Assessment of the Effect of BIIB021 in Subjects With Gastrointestinal Stromal Tumors (GIST) (NCT00618319) | Biogen | 2008-02-01 |
| Perifosine + Sunitinib Malate for Patients With Advanced Cancers (NCT00399152) | AEterna Zentaris | 2006-10-01 |